Wall Street's M&A Chatter From June 20: Calpine, Parexel, Gilead, Spherix-Hoth Therapeutics, Norsat-Hytera
Jun 21, 2017 - Benzinga

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday, June 20, 2017. PAREXEL to be Acquired for $88.10/Share Cash by Pamplona Capital The Deal: PAREXEL International Corporation (NASDAQ: PRXL) and Pamplona Capital Management, LLP have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of … (continue reading)

Would you like to track this news?

Click one of the buttons below or search.

Advanced Options | Search Tips